Göbl, C. ; Morris, V.K. ; van Dam, L.* ; Visscher, M.* ; Polderman, P.E.* ; Hartlmüller, C. ; de Ruiter, H.* ; Hora, M. ; Liesinger, L.* ; Birner-Gruenberger, R.* ; Vos, H.R.* ; Reif, B. ; Madl, T.* ; Dansen, T.B.*
Cysteine oxidation triggers amyloid fibril formation of the tumor suppressor p16(INK4A).
Redox Biol. 28:101316 (2020)
The tumor suppressor p16(INK4A) induces cell cycle arrest and senescence in response to oncogenic transformation and is therefore frequently lost in cancer. p16(INK4A) is also known to accumulate under conditions of oxidative stress. Thus, we hypothesized it could potentially be regulated by reversible oxidation of cysteines (redox signaling). Here we report that oxidation of the single cysteine in p16(INK4A) in human cells occurs under relatively mild oxidizing conditions and leads to disulfide-dependent dimerization. p16(INK4A) is an all a-helical protein, but we find that upon cysteine-dependent dimerization, p16(INK4A) undergoes a dramatic structural rearrangement and forms aggregates that have the typical features of amyloid fibrils, including binding of diagnostic dyes, presence of cross-beta sheet structure, and typical dimensions found in electron microscopy. p16(INK4A) amyloid formation abolishes its function as a Cyclin Dependent Kinase 4/6 inhibitor. Collectively, these observations mechanistically link the cellular redox state to the inactivation of p16(INK4A) through the formation of amyloid fibrils.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
Publication type
Article: Journal article
Document type
Scientific Article
Thesis type
Editors
Keywords
Amyloids ; Protein Aggregation ; Redox Signaling ; Cysteine Oxidation ; Structural Biology; Disulfide Bonds; Cell-cycle; Protein; Aggregation; Expression; Quantification; Form; Ftir
Keywords plus
Language
english
Publication Year
2020
Prepublished in Year
2019
HGF-reported in Year
2019
ISSN (print) / ISBN
2213-2317
e-ISSN
2213-2317
ISBN
Book Volume Title
Conference Title
Conference Date
Conference Location
Proceedings Title
Quellenangaben
Volume: 28,
Issue: ,
Pages: ,
Article Number: 101316
Supplement: ,
Series
Publisher
Elsevier
Publishing Place
Amsterdam [u.a.]
Day of Oral Examination
0000-00-00
Advisor
Referee
Examiner
Topic
University
University place
Faculty
Publication date
0000-00-00
Application date
0000-00-00
Patent owner
Further owners
Application country
Patent priority
Reviewing status
Peer reviewed
POF-Topic(s)
30203 - Molecular Targets and Therapies
Research field(s)
Enabling and Novel Technologies
PSP Element(s)
G-503090-001
G-503000-001
Grants
Copyright
Erfassungsdatum
2019-10-07